{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:47:22Z","timestamp":1790750842122,"version":"4.1.0"},"reference-count":50,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.20780","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T11:31:09Z","timestamp":1581075069000},"page":"e1920780","source":"Crossref","is-referenced-by-count":50,"title":["Association of Vascular Risk Factors With \u03b2-Amyloid Peptide and Tau Burdens in Cognitively Unimpaired Individuals and Its Interaction With Vascular Medication Use"],"prefix":"10.1001","volume":"3","author":[{"given":"Theresa","family":"K\u00f6be","sequence":"first","affiliation":[{"name":"Department of Psychiatry, McGill University, Montreal, Quebec, Canada"},{"name":"Studies on Prevention of Alzheimer\u2019s Disease Centre, Douglas Mental Health University Institute, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gonneaud","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, McGill University, Montreal, Quebec, Canada"},{"name":"Studies on Prevention of Alzheimer\u2019s Disease Centre, Douglas Mental Health University Institute, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Pichet Binette","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, McGill University, Montreal, Quebec, Canada"},{"name":"Studies on Prevention of Alzheimer\u2019s Disease Centre, Douglas Mental Health University Institute, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Meyer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, McGill University, Montreal, Quebec, Canada"},{"name":"Studies on Prevention of Alzheimer\u2019s Disease Centre, Douglas Mental Health University Institute, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"McSweeney","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, McGill University, Montreal, Quebec, Canada"},{"name":"Studies on Prevention of Alzheimer\u2019s Disease Centre, Douglas Mental Health University Institute, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, McGill University, Montreal, Quebec, Canada"},{"name":"Studies on Prevention of Alzheimer\u2019s Disease Centre, Douglas Mental Health University Institute, Montreal, Quebec, Canada"},{"name":"Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C. S.","family":"Breitner","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, McGill University, Montreal, Quebec, Canada"},{"name":"Studies on Prevention of Alzheimer\u2019s Disease Centre, Douglas Mental Health University Institute, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judes","family":"Poirier","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, McGill University, Montreal, Quebec, Canada"},{"name":"Studies on Prevention of Alzheimer\u2019s Disease Centre, Douglas Mental Health University Institute, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Villeneuve","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, McGill University, Montreal, Quebec, Canada"},{"name":"Studies on Prevention of Alzheimer\u2019s Disease Centre, Douglas Mental Health University Institute, Montreal, Quebec, Canada"},{"name":"Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada"},{"name":"McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Presymptomatic Evaluation of Experimental or Novel Treatments for Alzheimer Disease (PREVENT-AD) Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"issue":"12","key":"zoi190780r1","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders.","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"zoi190780r2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1001\/jamaneurol.2013.5390","article-title":"Associations between serum cholesterol levels and cerebral amyloidosis.","volume":"71","author":"Reed","year":"2014","journal-title":"JAMA Neurol"},{"issue":"5","key":"zoi190780r3","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1001\/jamaneurol.2013.1342","article-title":"Risk factors for \u00df-amyloid deposition in healthy aging: vascular and genetic effects.","volume":"70","author":"Rodrigue","year":"2013","journal-title":"JAMA Neurol"},{"issue":"4","key":"zoi190780r4","doi-asserted-by":"publisher","first-page":"827.e11","DOI":"10.1016\/j.neurobiolaging.2011.06.020","article-title":"Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons.","volume":"33","author":"Langbaum","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"23","key":"zoi190780r5","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1212\/01.wnl.0000436935.47657.78","article-title":"Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults.","volume":"81","author":"Nation","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"zoi190780r6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1212\/WNL.0000000000000550","article-title":"Vascular risk and A\u00df interact to reduce cortical thickness in AD vulnerable brain regions.","volume":"83","author":"Villeneuve","year":"2014","journal-title":"Neurology"},{"issue":"9","key":"zoi190780r7","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/j.neurobiolaging.2011.10.002","article-title":"Coronary risk correlates with cerebral amyloid deposition.","volume":"33","author":"Reed","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"5","key":"zoi190780r8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ana.v82.5","article-title":"Age, vascular health, and Alzheimer disease biomarkers in an elderly sample.","volume":"82","author":"Vemuri","year":"2017","journal-title":"Ann Neurol"},{"issue":"2","key":"zoi190780r9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3233\/JAD-170092","article-title":"Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition.","volume":"59","author":"Stephen","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"zoi190780r10","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1212\/WNL.0000000000005951","article-title":"Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology.","volume":"91","author":"Arvanitakis","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"zoi190780r11","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1001\/jamaneurol.2014.4477","article-title":"Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults.","volume":"72","author":"Nation","year":"2015","journal-title":"JAMA Neurol"},{"issue":"2","key":"zoi190780r12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ana.v85.2","article-title":"Vascular risk and \u00df-amyloid are synergistically associated with cortical tau.","volume":"85","author":"Rabin","year":"2019","journal-title":"Ann Neurol"},{"issue":"11","key":"zoi190780r13","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1111\/jgs.2009.57.issue-11","article-title":"Blood pressure and brain injury in older adults: findings from a community-based autopsy study.","volume":"57","author":"Wang","year":"2009","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"zoi190780r14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4103\/1673-5374.226426","article-title":"Neuroprotective effects of statins against amyloid \u00df-induced neurotoxicity.","volume":"13","author":"Li","year":"2018","journal-title":"Neural Regen Res"},{"key":"zoi190780r15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.dadm.2016.02.007","article-title":"Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects.","volume":"2","author":"Glodzik","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"zoi190780r16","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1038\/s41598-018-24248-8","article-title":"Use of statins and the risk of dementia and mild cognitive impairment: a systematic review and meta-analysis.","volume":"8","author":"Chu","year":"2018","journal-title":"Sci Rep"},{"issue":"12","key":"zoi190780r17","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/archneurol.2012.1010","article-title":"Impact of angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series.","volume":"69","author":"Hajjar","year":"2012","journal-title":"Arch Neurol"},{"issue":"6","key":"zoi190780r18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/GIM.0b013e31821d69b8","article-title":"Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors.","volume":"13","author":"Goldman","year":"2011","journal-title":"Genet Med"},{"issue":"4","key":"zoi190780r19","first-page":"236","article-title":"Rationale and structure for a new Center for Studies on Prevention of Alzheimer\u2019s Disease (StoP-AD).","volume":"3","author":"Breitner","year":"2016","journal-title":"J Prev Alzheimers Dis"},{"issue":"4","key":"zoi190780r20","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/jgs.2005.53.issue-4","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"zoi190780r21","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules.","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"3","key":"zoi190780r22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","article-title":"The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.","volume":"20","author":"Randolph","year":"1998","journal-title":"J Clin Exp Neuropsychol"},{"issue":"2","key":"zoi190780r23","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4103\/2230-8210.93742","article-title":"LIPITENSION: interplay between dyslipidemia and hypertension.","volume":"16","author":"Dalal","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"issue":"2 Pt 2","key":"zoi190780r24","first-page":"163","article-title":"High rates of co-occurrence of hypertension, elevated low-density lipoprotein cholesterol, and diabetes mellitus in a large managed care population.","volume":"10","author":"Selby","year":"2004","journal-title":"Am J Manag Care"},{"issue":"7","key":"zoi190780r25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/archinte.168.7.721","article-title":"Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial.","volume":"168","author":"Golomb","year":"2008","journal-title":"Arch Intern Med"},{"issue":"18","key":"zoi190780r26","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories.","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"zoi190780r27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3233\/JAD-170887","article-title":"Bi-directional association of cerebrospinal fluid immune markers with stage of Alzheimer\u2019s disease pathogenesis.","volume":"63","author":"Meyer","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"pt 7","key":"zoi190780r29","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1093\/brain\/awv112","article-title":"Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.","volume":"138","author":"Villeneuve","year":"2015","journal-title":"Brain"},{"key":"zoi190780r30","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.dib.2017.10.024","article-title":"Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data.","volume":"15","author":"Baker","year":"2017","journal-title":"Data Brief"},{"issue":"5","key":"zoi190780r31","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of tau deposition in the aging human brain.","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"issue":"11","key":"zoi190780r32","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u00df PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts.","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"4","key":"zoi190780r33","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1212\/WNL.0000000000004860","article-title":"Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample.","volume":"90","author":"La Joie","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"zoi190780r34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u00df deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study.","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"issue":"10","key":"zoi190780r35","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/jnen\/nlw072","article-title":"Late-life vascular risk factors and Alzheimer disease neuropathology in individuals with normal cognition.","volume":"75","author":"Besser","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"zoi190780r36","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.neurobiolaging.2013.09.040","article-title":"Markers of cholesterol transport are associated with amyloid deposition in the brain.","volume":"35","author":"Hughes","year":"2014","journal-title":"Neurobiol Aging"},{"key":"zoi190780r37","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.2741\/2839","article-title":"The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer\u2019s disease: new therapeutic potential.","volume":"13","author":"Takeda","year":"2008","journal-title":"Front Biosci"},{"issue":"6","key":"zoi190780r38","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1212\/WNL.0b013e318228bf11","article-title":"A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease.","volume":"77","author":"Sano","year":"2011","journal-title":"Neurology"},{"key":"zoi190780r39","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4368474","article-title":"Association between antihypertensive drug use and the incidence of cognitive decline and dementia: a meta-analysis of prospective cohort studies.","volume":"2017","author":"Xu","year":"2017","journal-title":"Biomed Res Int"},{"issue":"14","key":"zoi190780r40","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1001\/jama.2017.3090","article-title":"Association between midlife vascular risk factors and estimated brain amyloid deposition.","volume":"317","author":"Gottesman","year":"2017","journal-title":"JAMA"},{"issue":"22","key":"zoi190780r41","doi-asserted-by":"publisher","first-page":"13266","DOI":"10.1073\/pnas.95.22.13266","article-title":"Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis.","volume":"95","author":"Liu","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"zoi190780r42","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1161\/STROKEAHA.108.536839","article-title":"Beta-amyloid, blood vessels, and brain function.","volume":"40","author":"Smith","year":"2009","journal-title":"Stroke"},{"issue":"4","key":"zoi190780r43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nn0403-345","article-title":"Alzheimer\u2019s disease: the cholesterol connection.","volume":"6","author":"Puglielli","year":"2003","journal-title":"Nat Neurosci"},{"issue":"1-2","key":"zoi190780r44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0009-8981(99)00097-2","article-title":"Apolipoprotein E and atherosclerosis: insight from animal and human studies.","volume":"286","author":"Davignon","year":"1999","journal-title":"Clin Chim Acta"},{"issue":"1","key":"zoi190780r45","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ana.v67:1","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.","volume":"67","author":"Morris","year":"2010","journal-title":"Ann Neurol"},{"issue":"11","key":"zoi190780r46","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1212\/WNL.0000000000001379","article-title":"Effects of vascular risk factors and APOE e4 on white matter integrity and cognitive decline.","volume":"84","author":"Wang","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"zoi190780r47","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/jamaneurol.2018.1123","article-title":"Interactive associations of vascular risk and \u00df-amyloid burden with cognitive decline in clinically normal elderly individuals: findings from the Harvard Aging Brain Study.","volume":"75","author":"Rabin","year":"2018","journal-title":"JAMA Neurol"},{"issue":"9","key":"zoi190780r48","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.jalz.2019.04.015","article-title":"Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer\u2019s disease.","volume":"15","author":"Bos","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"pt 4","key":"zoi190780r49","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/brain\/aww015","article-title":"Cerebrospinal fluid analysis detects cerebral amyloid-\u00df accumulation earlier than positron emission tomography.","volume":"139","author":"Palmqvist","year":"2016","journal-title":"Brain"},{"issue":"10","key":"zoi190780r50","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.jacc.2003.11.061","article-title":"The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III.","volume":"43","author":"Ford","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"zoi190780r28","unstructured":"GitHub. Villeneuve Laboratory PET Pipeline. https:\/\/github.com\/villeneuvelab\/vlpp. Accessed December 18, 2019."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2760441\/kbe_2020_oi_190780.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T07:47:57Z","timestamp":1614325677000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2760441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.20780","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,7]]}}}